Sort
50,496 grants matching “lung cancer”
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
$632,501Wilfred Ngwa · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
$632,501Wilfred Ngwa · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
$632,407Carla F. Kim · Boston Children'S Hospital · R01 · FY2022 · CA
Structural Bioinformatics
$632,407Byungkook Lee · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Provider Support and Patient Outreach in Lung Cancer Screening
$632,323Ronald E Myers · Thomas Jefferson University · R01 · FY2023 · CA
Ultrahigh-throughput imaging of 3D tumor microenvironment at nanoscale
$632,300Yongxin Zhao · Carnegie-Mellon University · R01 · FY2025 · CA
Mechanistic factors limiting utility of adenovirus vectors for treatment of neopla
$632,232Dmitry Shayakhmetov · Emory University · R01 · FY2022 · CA
Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung Cancer
$632,185Zihai Li · Ohio State University · R01 · FY2025 · CA
A surface chemistry guided approach to the rational design of low-energy electron emitting nanomaterials
$632,142Charles Emile Sykes · Tufts University Medford · R56 · FY2020 · EB
Macro-vasculature: A Novel Image Biomarker of Lung Cance
$632,139Jiantao Pu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$632,135Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · CA
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$632,109Nicholas C Denko · Ohio State University · R01 · FY2022 · CA
Novel metabolomic contrast probes for human lung cancer characterization
$632,094Christian T Farrar · Massachusetts General Hospital · R01 · FY2024 · CA
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$632,039Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
$632,028John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2017 · CA
Immune Compromises Zebrafish for Cell Transplantation
$632,028David Michael Langenau · Massachusetts General Hospital · R24 · FY2013 · OD
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer
$632,011Maximilian Diehn · Stanford University · R01 · FY2021 · CA
Secondary Prevention through Surveillance and Intervention
$632,007Lewis A Chodosh · University Of Pennsylvania · R01 · FY2019 · CA
Exploratory Research on HIV Contribution to Heart and Lung Comorbidities
$631,968Andrew G Maclean · Tulane University Of Louisiana · R01 · FY2020 · HL
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$631,958Cristian T Badea · Duke University · U24 · FY2018 · CA
CANCAN - ROCHESTER
$631,930Karen M Mustian · University Of Rochester · OT2 · FY2025 · CA
Optimizing Individualized and Adaptive mHealth Interventions via Control Systems Engineering Methods
$631,918Eric Hekler · University Of California, San Diego · R01 · FY2021 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$631,889Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevance
$631,853Emil Schueler · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Advancing Tobacco Use Treatment for African American Smokers
$631,776Lisa Sanderson Cox · University Of Kansas Medical Center · R01 · FY2015 · DA